The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Collectible Investments: U.S. patent medicine tax stamps

 Sep 09, 2009 09:40 PM UTC
Return Risk
-17.65% MID
Tracked Blogger

Graphic_arrow1 Via BloggingStocks:  

Filed under: Other issues, Columns

Can investing and collecting go hand-in-hand? Yes -- especially if you are collecting coins, stock certificates, bank notes, or other rare items of value. Larry Schutts, an expert in investment-related collectibles, will periodically review items of interest from his collection and answer your questions here.


In the summer of 1862, the rising costs of the Civil War prompted the U.S. Congress to enact a broad new tax program. The Revenue Act of 1862 created the office of the Commissioner of Internal Revenue and introduced Americans to their first progressive rate income tax. The Act also required that taxes be paid on documented business transactions and on the sale of certain proprietary retail goods. In order to prove payment, citizens and businesses bought government-issued revenue stamps and applied them to their documents and merchandise. On the documentary side, the inconvenience of dealing with stamps led many to order such paper goods as checks and stock certificates with government-approved stamp designs already printed on them. Retailers, on the other hand, quickly saw the advertising possibilities and were ultimately granted permission to obtain stamps bearing their own private labels.

Continue reading Collectible Investments: U.S. patent medicine tax stamps

Collectible Investments: U.S. patent medicine tax stamps originally appeared on BloggingStocks on Wed, 09 Sep 2009 16:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati




 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch